NewAmsterdam Pharma Company NV (NAMSW) Q3 2024 Earnings

7AugConfirmed
Q2 2024
Q3 2024
-1.06
-0.84
-0.63
-0.41

Details

Expected EPS
-0.576825
Actual EPS
-0.41
Surprise EPS
0.17
Surprise Percent
+28.92%

Description

NewAmsterdam Pharma Company NV (NAMSW) has reported earnings of -0.41 per share for Q3 2024.

0 Comments

Share your thoughts